SWARTZ ROBIN (Chief Operating Officer) received a stock award from VOYAGER THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/16/2024ACC: 0001104659-24-024989
Officer· Chief Operating Officer
Since Feb 2022
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
69.1%
2/9/2024
72.33K→122.33K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2024 | A · Award | +50K | — | — | 69.1% | 72.33K | 122.33K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
100K shares
Shares
+100K
Strike price
7.60
Held after
100K
Exercisable
—
2/9/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock100K shares | 2/9/2024 | A · Award | +100K | 7.60 | — | 100K |